Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00756236 · ClinicalTrials.gov registry record · NA

A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement

A NA study of Myocardial Ischemia, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT00756236 is a NA study of Myocardial Ischemia that has completed, run by University of Oklahoma. The registered enrollment target is 60 participants, below the 2,136-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00756236, a NA study of Myocardial Ischemia, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

We will compare three study groups receiving metoprolol, esmolol, or placebo. Level of anesthesia will be titrated to achieve the same range of BIS value in all groups. Our hypothesis is that the metoprolol and esmolol groups will require a lower level of anesthetic agent to achieve the targeted BIS range, compared to the placebo group. Our objective is to clarify if metoprolol, in a dose range used for perioperative cardiac protection, decreases anesthetic requirement.

Conditions Studied

Interventions

  • DRUG Metoprolol
  • DRUG Esmolol
  • DRUG P-Group

Study Locations (1)

Oklahoma

  • Univeristy of Oklahoma Health Sciences Center Dept. Anesthesiology - Oklahoma City

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2008-10
Est. Completion 2015-09-02
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT00756236

The ClinicalTrials.gov registry entry for NCT00756236 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,136-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (97% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myocardial Ischemia appearing as the primary indexed condition, and to 3 interventions - of which Metoprolol is the first listed.

NCT00756236 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT00756236 about?

NCT00756236 is a clinical study titled "A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement". We will compare three study groups receiving metoprolol, esmolol, or placebo. Level of anesthesia will be titrated to achieve the same range of BIS value in all groups. Our hypothesis is that the metoprolol and esmolol groups will require a lower level of anesthetic agent to achieve the targeted BIS...

What is the current status of trial NCT00756236?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2008-10. Estimated completion is 2015-09-02.

What conditions does trial NCT00756236 study?

This clinical trial studies the following conditions: Myocardial Ischemia.

What interventions are being tested in trial NCT00756236?

The interventions under investigation include: Metoprolol (DRUG), Esmolol (DRUG), P-Group (DRUG).

Who is sponsoring clinical trial NCT00756236?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00756236 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myocardial Ischemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.